Expression of BCL-2, BAX and BAK in the trophoblast layer of the term human placenta: A unique model of apoptosis within a syncytium

Placenta

Volumn 21, Issue 4, 2000, Pages 361-366

  Ratts, V S ^a   Tao, X J ^b   Webster, C B ^a   Swanson, P E ^a   Smith, S D ^a   Brownbill, P ^c   Krajewski, S ^d   Reed, J C ^d   Tilly, J L ^b   Nelson, D M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c ST MARY S HOSPITAL   (United Kingdom)

^d BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; FIBRIN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NICK END LABELING; NORMAL HUMAN; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNCYTIOTROPHOBLAST; SYNCYTIUM; TROPHOBLAST;

EID: 18744431478     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.1999.0486     Document Type: Article

References (35)

1. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI, Guild BC. Induction of apoptosis by the Bcl-2 homologue Bak. Nature. 374:1995;733-736.
2. Chittenden T, Flemington C, Houghton AB, Ebb GE, Gallo GJ, Elangovan B, Chinnadurai G, Lutz RJ. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J. 14:1995;5589-5596.
3. Cohen GM. Caspases: the executioners of apoptosis. Biochem J. 326:1997;1-16.
4. Frank HG, Malekzadeh F, Kertschanska S, Crescimanno C, Castellucci M, Lang I, Desoye G, Kaufman P. Immunohistochemistry of two different types of placental fibrinoid. Acta Anat. 150:1994;53-68.
5. Gavrieli Y, Sherman Y, Ben-Sasson A. Identification of programmed cell death in situ via specific labeling of nuclear DNA framentation. J Cell Biol. 119:1992;493-501.
6. Ho S, Winkler-Lowen B, Morrish DW, Dakour J, Li H, Guilbert LJ. The role of bcl-2 expression in EGF inhibition of TNF-α/IFN-γ-induced villous trophoblast apoptosis. Placenta. 20:1999;423-430.
7. Hsu S-M, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques; a comparison between ABC and unlabeled antibody procedures. J Histochem Cytochem. 29:1981;577-580.
8. Huppertz B, Frank HG, Kingdom JCP, Reister F, Kaufmann P. Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta. Histochem Cell Biol. 110:1998;495-508.
9. Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR, Tomei LD, Barr PJ. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature. 374:1995;736-739.
10. Knudson CM, Korsmeyer SJ. Bcl-2 and Bax function independently to regulate cell death. Nature Genet. 16:1997;358-363.
11. Krajewski S, Krajewski M, Shabaik A, Miyashita T, Wang H-G, Reed JC. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol. 145:1994;1323-1336.
12. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med. 3:1997;614-620.
13. Kugu K, Ratts VS, Piquette GN, Tilly KI, Tao XJ, Salib JB, Martimbeau S, Aberdeen GW, Reed JC, Pepe GJ, Albrecht ED, Tilly JL. Analysis of apoptosis and expression of bcl-2 gene family members in the human and baboon ovary. Cell Death Differ. 5:1998;67-76.
14. Martimbeau S, Tilly JL. Physiological cell death in endocrine-dependent tissues: an ovarian perspective. Clin Endocrinol. 46:1997;241-254.
15. Marzioni D, Muhlhauser J, Crescimanno C, Banita M, Pierleoni C, Castellucci M. BCL-2 expression in the human placenta and its correlation with fibrin deposits. Human Reprod. 13:1998;1717-1722.
16. Mayhew TM, Leach L, McGee R, Wan Ismail W, Myklebust R, Lammiman MJ. Proliferation, differentiation and apoptosis in villous trophoblast at 13-41 weeks of gestation (including observations on annulate lamellae and nuclear pore complexes). Placenta. 20:1999;407-422.
17. Nelson DM. Apoptotic changes occur in syncytiotrophoblast of human placental villi where fibrin type fibrinoid is deposited at discontinuities in the villous trophoblast. Placenta. 17:1996;387-391.
18. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:1993;609-619.
19. Qiao S, Nagasaka T, Harada T, Nakashima N. p53, Bax and Bcl-2 expression, and apoptosis in gestational trophoblast of complete hydatidiform mole. Placenta. 19:1998;361-369.
20. Reed JC. Double identity for proteins of the Bcl-2 family. Nature. 387:1997;773-776.
21. Sakuragi N, Matsuo H, Coukos G, Furth EE, Bronner MP, Van Arsdale CM, Krajewsky S, Reed JC, Strauss III JF. Differentiation-dependent expression of the BCL-2 proto-oncogene in the human trophoblast lineage. J Soc Gynecol Invest. 1:1994;164-172.
22. Sato T, Hanada M, Bodrug S, Irie S, Iwama N, Boise LH, Thompson CB, Golemis E, Fong L, Wang H-G, Reed J. Interactions among member of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci USA. 91:1994;9238-9242.
23. Sedlak TW, Oltvai ZN, Yang E, Wang K, Boise LH, Thompson CB, Korsmeyer SJ. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc Natl Acad Sci USA. 92:1995;7834-7838.
24. Smith SC, Baker PN, Symonds EM. Placental apoptosis in normal human pregnancy. Am J Obstet Gynecol. 177:1997;57-65.
25. Smith SC, Baker PN, Symonds EM. Increased placental apoptosis in intrauterine growth restriction. Am J Obstet Gynecol. 177:1997;1395-1401.
26. Steller H. Mechanisms and genes of cellular suicide. Science. 267:1995;1445-1449.
27. Swanson PE, Humphrey PA, Dehner LP. Immunoreactivity for bcl-2 protein in peripheral primitive neuroectodermal tumors. Appl Immunohistochem. 1:1993;182-187.
28. Tao X-J, Tilly KI, Maravei DV, Shifren JL, Krajewski S, Reed JC, Tilly JL, Isaacson KB. Differential expression of members of the bcl-2 gene family in proliferative and secretory human endometrium: glandular epithelial cell apoptosis is associated with increased expression of bax. J Clin Endocrin Metab. 82:1997;2738-2746.
29. Tao X-J, Sayegh RA, Tilly JL, Issacson KB. Elevated expression of the pro-apoptotic BCL-2 family member, BAK, in the human endometrium coincident with apoptosis during the secretory phase of the cycle. Fertil Steril. 70:1998;338-343.
30. Tilly JL. Use of terminal transferase DNA labeling reaction for the biochemical and in situ analysis of apoptosis. Celis JE. Cell Biology: A Laboratory Handbook. 1994;330-337 Academic Press, San Diego.
31. Toshihiko T, Horiuchi A, Ichikawa N, Mori A, Nikaido T, Fujii S. Inverse relationship between apoptosis and Bcl-2 expression in syncytiotrophoblast and fibrin-type fibrinoid in early gestation. Mol Human Reprod. 5:1999;246-251.
32. Yang E, Korsmeyer SJ. Molecular thanatopsis: a discourse on the BCL-2 family and cell death. Blood. 88:1996;386-401.
33. Yin X-M, Oltvai ZN, Korsmeyer SJ. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature. 369:1994;321-323.
34. Yui J, Garcia-Lloret M, Wegmann TG, Guilbert LJ. Cytotoxicity of tumour necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts. Placenta. 15:1994;819-835.
35. Zha H, Reed JC. Heterodimerization-independent functions of cell death regulatory proteins Bax and Bcl-2 in yeast and mammalian cells. J Biol Chem. 272:1997;31 482-31 488.